Home
Samsara BioCapital, 10% Owner: Neurogene NGNE Buy · Filed 24/11/27
Trade details
- Type
- Insider buy
- Amount
- $55,000
- Shares · price
- 2,000 sh · $27.50 a share
- Held after
- 1,717,127 sh
- Stock
- Neurogene NGNE
- Trade date
- 24/11/26
- Filed
- 24/11/27
- Days to filing
- 1 days
First buy since 2023
- Insiders buying this week
- 5 insiders
- Holding change
- +0.1%
Neurogene trades, last 26 weeks
What else happened in Neurogene around then
Filed or reported within 30 days of the trade day · 24/10/27~24/12/26Samsara BioCapital's recent trades
- Samsara BioCapital
BuyKalaris Therapeutics
BuyKalaris Therapeutics
KLRS
$1.2M
244,300 sh
$1.2M
Filed 05/22
Traded 05/20
- Samsara BioCapital
BuyKalaris Therapeutics
BuyKalaris Therapeutics
KLRS
$5M
479,847 sh
$5M
Filed 02/17
Traded 25/12/18
- Samsara BioCapital
BuyMineralys Therapeutics
BuyMineralys Therapeutics
MLYS
$8.1M
600,000 sh
$8.1M
Filed 25/03/17
Traded 25/03/13
- Samsara BioCapital
BuyNeurogene
BuyNeurogene
NGNE
$516.8K
20,748 sh
$516.8K
Filed 24/11/27
Traded 24/11/26
- Samsara BioCapital
BuyNeurogene
BuyNeurogene
NGNE
$406.8K
15,219 sh
$406.8K
Filed 24/11/27
Traded 24/11/26